Efficacy and safety of 0.1% ciclosporin A cationic emulsion in dry eye disease: a pooled analysis of two double-masked, randomised, vehicle-controlled phase III clinical studies

BACKGROUND/AIM: To assess the treatment effect of 0.1% ciclosporin A cationic emulsion (CsA CE) versus vehicle on signs/symptoms of dry eye disease (DED) in various subgroups (moderate-to-severe DED/severe DED/Sjögren’s syndrome (SS)/SS with severe DED). METHODS: Pooled data were analysed from two s...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonardi, Andrea, Messmer, Elisabeth M, Labetoulle, Marc, Amrane, Mourad, Garrigue, Jean-Sébastien, Ismail, Dahlia, Sainz-de-la-Maza, Maite, Figueiredo, Francisco C, Baudouin, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317444/
https://www.ncbi.nlm.nih.gov/pubmed/29545413
http://dx.doi.org/10.1136/bjophthalmol-2017-311801

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6317444/
https://www.ncbi.nlm.nih.gov/pubmed/29545413
http://dx.doi.org/10.1136/bjophthalmol-2017-311801

Ejemplares similares